Woodline Partners’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
BIP
Woodline Partners's PBH Position: Q2 2026 in Review
Woodline Partners increased its Prestige Consumer Healthcare (PBH) stake by 31% in Q2 2026, buying an estimated $4.41M and bringing the position to 359,721 shares worth $17M. The position accounts for 0.05% of the portfolio, ranked #405.
Woodline Partners first reported a position in PBH in Q3 2021 and has held it in 7 quarters since. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Woodline Partners held 359,721 shares of Prestige Consumer Healthcare worth $17M as of Q2 2026.
- Woodline Partners bought 85,778 Prestige Consumer Healthcare shares in Q2 2026, an estimated $4.41M.
- Prestige Consumer Healthcare made up 0.05% of Woodline Partners's portfolio in Q2 2026, its #405 holding.
- Woodline Partners first reported a position in Prestige Consumer Healthcare in Q3 2021 and has held it in 7 quarters since.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.